The White House issued an executive order suspending tariffs on fertilizer imports, drawing applause from farm groups. The move is designed to reduce input costs for U.S. agricultural producers ahead of the planting season, and comes as the administration faces pressure to show tangible economic relief from its broader tariff agenda.
Trump's Fertilizer Tariff Suspension Cuts Input Costs for Farmers — and Squeezes Domestic Producers
Cheaper imported fertilizer helps crop margins but undercuts the U.S. companies that make the stuff.

Suspending fertilizer tariffs is a direct transfer from domestic producers like Mosaic and CF Industries to the farmers who buy from them.
Who cashes in: U.S. farmers and agricultural operators are the direct beneficiaries — lower fertilizer costs improve margins on corn, soybeans, and wheat. The clearest public-market expression of this is Archer-Daniels-Midland (ADM) and Bunge Global (BG), which process and trade grain and benefit when farmer economics improve and supply flows. Deere & Company (DE) benefits indirectly — healthier farm income supports equipment purchases and financing. Mosaic Company (MOS) and CF Industries (CF) are the names to watch on the other side.
Who's exposed: Mosaic (MOS) and CF Industries (CF) are the two largest U.S.-listed fertilizer producers. Suspended tariffs on imports mean cheaper foreign competition — primarily from Canada, Russia, and the Middle East — can undercut their pricing. Both stocks have already been under pressure from global potash and nitrogen oversupply; this adds a policy headwind on top of a commodity one. Nutrien (NTR), the Canadian potash giant listed in New York, is in an unusual position: it's a foreign producer that benefits from tariff relief on its U.S. exports, making it a relative winner versus domestic peers.
What to watch next: The specific scope of the suspension — which fertilizers, which countries, and for how long. A broad, indefinite suspension is structurally bearish for MOS and CF. A narrow, time-limited one is a temporary headwind. Watch MOS and CF earnings calls for guidance revisions and any commentary on whether they're lobbying for countervailing duties.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.